The demand for image-based diagnostics is increasing globally and includes medical fields such as pathology, radiology, ophthalmology and dermatology. This combined with limited expert resources and continuous issues with observer variability, have led to a significant demand for more efficient workflows, highly-accurate diagnosis, novel therapeutics, and personalized care. The Aiforia Platform was created to address these challenges and provide versatile and scalable solutions for medical research, drug development, and diagnostics.
Aiforia Technologies was founded as a spin-off company from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki in 2013 by researchers and pioneers in the field of cloud-based microscopy and pathology, and experienced life science entrepreneurs. The Aiforia® Platform brings together image-based AI and high-performance cloud computing, optimized in particular for enormous images in the field of digital pathology. Built on an intuitive user interface, it is the only one on the market where no local hardware or prior computing knowledge is needed to train and apply advanced deep learning models to analytical and diagnostic tasks.
The platform has so far been used successfully in the development and application of a comprehensive series of challenging analyses for cancer, neurological disorders (e.g. Parkinson’s disease), liver diseases (e.g. nonalcoholic steatohepatitis — NASH), and for numerous other research purposes. Aiforia represents a major breakthrough in the field of AI-powered image analysis, as it is designed for domain expert use as well as applicable in any medical discipline or research area.
Why deep learning?
Deep learning AI is reshaping and revolutionizing image analysis, far surpassing basic machine learning’s capability. The Aiforia Platform is powered by deep convolutional neural networks, which provide great power and flexibility to automate highly complex analyses. Unlike conventional machine learning technologies, the deep neural network architecture enables completely novel research approaches that have not been possible before, often surpassing human capability.
Aiforia’s mission is to provide global access to AI-powered image analysis, to be used by healthcare professionals and researchers within a broad spectrum of fields. Our tools will improve their workflow efficiency and scalability — enabling new discoveries, better-informed decisions, and more personalized patient care.
We believe that artificial intelligence will fundamentally transform image-based diagnostics from subjective and manual to consistent and automated processes. Our ambition is to be the global leader in this field — providing the most intelligent tools to democratize healthcare globally.
We are a comprehensive mix of experienced scientists and entrepreneurs. Our team brings together expertise in the medical and pharmaceutical industries as well as in the computer technology and business-to-business software sectors.Meet our team
Cambridge Innovation Center, 14th Floor
1 Broadway, Cambridge, MA 02142, United States
Tel: +1 (508) 981 5474
Aiforia Technologies Oy
Biomedicum 2 U
Tukholmankatu 8 FI-00290 Helsinki, Finland
Tel: +358 20 734 9130